MicroRNA Regulator Disappears as Normal Cells Become Cancerous
By LabMedica International staff writers Posted on 17 Jul 2012 |
The loss of a major regulatory microRNA may trigger a shift in metabolic pathways that promote changes in cellular behavior including those that transform normal cells into cancerous ones.
Investigators at Ohio State University (Columbus, USA) used cell cultures derived from samples obtained from patients with either the aggressive or the indolent form of chronic lymphocytic leukemia (CLL) in order to evaluate the role of the regulatory microRNA miR-125b in this cancer.
They reported in the June 21, 2012, online edition of the journal Blood that that both aggressive and indolent CLL patients showed reduced expression of miR-125b. The loss of miR-125b activity was associated with higher rates of glucose metabolism, a characteristic of cancer cells known as the Warburg effect.
“Our findings indicate that miR-125b is downregulated in both aggressive and indolent forms of CLL, and that this downregulation is associated with metabolic adaptation to cancer transformation," said senior author Dr. Carlo Croce, professor of immunology and medical genetics at Ohio State University. “By identifying the metabolites that are changed, as we have here, we can propose to use drugs that target them and perhaps control the leukemia.”
“Cancer is a complex disease,” said Dr. Croce. “The more we know about the changes that occur when cells become malignant, the better therapies we can design.”
Related Links:
Ohio State University
Investigators at Ohio State University (Columbus, USA) used cell cultures derived from samples obtained from patients with either the aggressive or the indolent form of chronic lymphocytic leukemia (CLL) in order to evaluate the role of the regulatory microRNA miR-125b in this cancer.
They reported in the June 21, 2012, online edition of the journal Blood that that both aggressive and indolent CLL patients showed reduced expression of miR-125b. The loss of miR-125b activity was associated with higher rates of glucose metabolism, a characteristic of cancer cells known as the Warburg effect.
“Our findings indicate that miR-125b is downregulated in both aggressive and indolent forms of CLL, and that this downregulation is associated with metabolic adaptation to cancer transformation," said senior author Dr. Carlo Croce, professor of immunology and medical genetics at Ohio State University. “By identifying the metabolites that are changed, as we have here, we can propose to use drugs that target them and perhaps control the leukemia.”
“Cancer is a complex disease,” said Dr. Croce. “The more we know about the changes that occur when cells become malignant, the better therapies we can design.”
Related Links:
Ohio State University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples